CO2017004809A2 - Composiciones de triptamidas - Google Patents

Composiciones de triptamidas

Info

Publication number
CO2017004809A2
CO2017004809A2 CONC2017/0004809A CO2017004809A CO2017004809A2 CO 2017004809 A2 CO2017004809 A2 CO 2017004809A2 CO 2017004809 A CO2017004809 A CO 2017004809A CO 2017004809 A2 CO2017004809 A2 CO 2017004809A2
Authority
CO
Colombia
Prior art keywords
tryptamides
tryptamide
compositions
eluting
eht
Prior art date
Application number
CONC2017/0004809A
Other languages
English (en)
Inventor
Jeffry Stock
Maxwell Stock
Michael Voronkov
Jose Fernandez
Kristen Huber
Original Assignee
Signum Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Signum Biosciences Inc filed Critical Signum Biosciences Inc
Publication of CO2017004809A2 publication Critical patent/CO2017004809A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415—Pyridoxine, i.e. Vitamin B6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/74—Rubiaceae (Madder family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C07D209/16—Tryptamines

Abstract

[0001] Un extracto de EHT que incluye una mezcla de triptamidas de elución tardía y triptamidas de elución temprana en una proporción de pesos de por lo menos aproximadamente 7:1 de triptamidas de elución tardía:triptamidas de elución temprana, en donde el extracto de EHT incluye por lo menos un 30% de eicosanoil-5-hidroxitriptamida, basado en el peso total de las triptamidas en el extracto de EHT.
CONC2017/0004809A 2014-10-15 2017-05-12 Composiciones de triptamidas CO2017004809A2 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462063983P 2014-10-15 2014-10-15
US201562121711P 2015-02-27 2015-02-27
PCT/US2015/055745 WO2016061357A1 (en) 2014-10-15 2015-10-15 Tryptamide compositions and methods of use

Publications (1)

Publication Number Publication Date
CO2017004809A2 true CO2017004809A2 (es) 2017-11-21

Family

ID=55747349

Family Applications (1)

Application Number Title Priority Date Filing Date
CONC2017/0004809A CO2017004809A2 (es) 2014-10-15 2017-05-12 Composiciones de triptamidas

Country Status (13)

Country Link
US (1) US10314817B2 (es)
EP (1) EP3207029B1 (es)
JP (2) JP7179459B2 (es)
KR (1) KR20170066645A (es)
CN (1) CN107108495B (es)
AU (1) AU2015332434A1 (es)
CA (1) CA2963982C (es)
CO (1) CO2017004809A2 (es)
HK (1) HK1243404A1 (es)
MX (1) MX2017004909A (es)
PE (1) PE20171059A1 (es)
TW (1) TW201630882A (es)
WO (1) WO2016061357A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106565588A (zh) * 2016-11-10 2017-04-19 徐州工程学院 一种从坚果中提取食物源二十烷酸‑5‑羟色胺的方法
WO2020092930A1 (en) * 2018-11-02 2020-05-07 Rutgers, The State University Of New Jersey Synergistic composition having neuroprotective properties and methods of use thereof
US11896600B2 (en) * 2019-09-21 2024-02-13 Vidya Herbs, Inc. Composition and method of using eicosanoyl-5-hydroxytryptamide for treating neurodegenerative disorders

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2639066A1 (de) * 1976-08-30 1978-03-02 Hag Ag Verfahren zur entfernung von reizstoffen aus kaffee
ES2153447T3 (es) * 1994-07-23 2001-03-01 Nestle Sa Composicion antioxidante y procedimiento para su preparacion.
JPH08157816A (ja) * 1994-12-02 1996-06-18 Oriza Yuka Kk 天然抗酸化剤およびその製造方法
US9486441B2 (en) * 2008-04-21 2016-11-08 Signum Biosciences, Inc. Compounds, compositions and methods for making the same
DE202008005965U1 (de) * 2008-04-30 2008-12-11 Metsälä, Pertti Nahrungszusammensetzung
EP2382868A1 (en) * 2010-04-30 2011-11-02 Tchibo GmbH Healthy coffee and method of its production
EP2627199B1 (en) * 2010-10-13 2017-04-19 Koninklijke Douwe Egberts B.V. Coffee extracts as ingredients of foods, drugs, cosmetics, dietary supplements, and biologics
SG193355A1 (en) * 2011-03-10 2013-10-30 Takasago Perfumery Co Ltd Taste improvement agent
US8877766B2 (en) * 2013-02-15 2014-11-04 Peter F. Kador Neuroprotective multifunctional antioxidants and their monofunctional analogs

Also Published As

Publication number Publication date
HK1243404A1 (zh) 2018-07-13
CA2963982A1 (en) 2016-04-21
JP2017531698A (ja) 2017-10-26
EP3207029B1 (en) 2021-08-04
JP7179459B2 (ja) 2022-11-29
MX2017004909A (es) 2018-02-12
US20170231955A1 (en) 2017-08-17
PE20171059A1 (es) 2017-07-21
CA2963982C (en) 2022-11-29
KR20170066645A (ko) 2017-06-14
US10314817B2 (en) 2019-06-11
EP3207029A4 (en) 2018-05-02
CN107108495A (zh) 2017-08-29
TW201630882A (zh) 2016-09-01
EP3207029A1 (en) 2017-08-23
AU2015332434A1 (en) 2017-04-20
WO2016061357A1 (en) 2016-04-21
JP2021059543A (ja) 2021-04-15
CN107108495B (zh) 2021-07-16

Similar Documents

Publication Publication Date Title
CO2017001994A2 (es) Compuestos activos hacia bromodominios
CL2023000198A1 (es) Derivado de glucagón y una composición que comprende un conjugado de acción prolongada del mismo
CL2016002772A1 (es) Composiciones de insulina de rápida acción
CR20160419A (es) Nuevos compuestos biciclicos
DOP2016000165A (es) Mezclas fungicidas sinérgicas para el control fúngico en cereales
BR112017018276A2 (pt) ?composição que compreende peptidase e biotensoativo e seu uso?
CL2015002677A1 (es) Composiciones que comprenden selenio y uso de las mismas para el tratamiento y prevención de enfermedades o condiciones asociadas con la disfunción mitocondrial.
AR100498A1 (es) Mejora en la reducción de la fricción
WO2018097665A3 (ko) 코팅 조성물 및 유기 발광 소자
MX2022015755A (es) Profarmacos de hormona paratiroidea (pth).
CL2015002891A1 (es) Deaza-purinonas macrocíclicas para el tratamiento de infecciones virales.
BR112017006137A2 (pt) formulação que contém biotensoativo
CR20160418A (es) Nuevos compuestos biciclicos de 7 eslabones
AR100374A1 (es) Composición de limpieza antimicrobiana
IL273300A (en) High dose valbenazine formulation and related preparations, methods and kits
MX2019009842A (es) Composicion solida que comprende sofosbuvir amorfo.
PH12017500555A1 (en) Modified phosphpors and compositions thereof
MX2016000450A (es) Mezclas activas.
CR20170425A (es) Nuevas proteínas específicas para pioverdina y pioquelina
BR112016006048A8 (pt) composições antimicrobianas
CO2017010091A2 (es) Composiciones tópicas que comprenden un corticosteroide
PH12015502014A1 (en) Racecadotril lipid compositions
MX369223B (es) Composiciones de protector solar.
CL2015001955A1 (es) Método para preparar fideos instantáneos, composición de harina para fideos instantáneos y uso de la misma.
BR112017002090A2 (pt) formulação de fator viii